Emerging data identify molecular subtypes of Long COVID, link pediatric disease to school absenteeism, and define occupational risk factors for persistent symptoms.
The FDA has authorized a first-of-its-kind therapeutic device that delivers tumor-treating fields for adults with locally advanced pancreatic cancer. The approval offers a new non-invasive option to extend...
The FDA approval expands frontline treatment options for adults with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplant, based on randomized trial data showing...
HHS and the Department of Agriculture unveiled new dietary guidelines and an updated food pyramid for Americans. According to HHS, these changes mark a shift toward prioritizing health outcomes rather than...
The CDC has adopted updated pediatric immunization recommendations following a presidential memorandum requesting a comprehensive scientific assessment of immunization practices in peer countries.
The FDA has cleared a once-daily oral semaglutide treatment for adults with obesity or overweight and weight-related conditions, based on phase 3 OASIS 4 trial results demonstrating significant mean weight...
A new ACC/AHA clinical practice guideline on managing adults with congenital heart disease updates its 2018 recommendations by integrating evidence from 2017 to 2024 and emphasizing specialized...
On Friday, the Advisory Committee on Immunization Practices voted 8-3 on major changes to the long-standing universal hepatitis B birth-dose policy, introducing shared decision-making for infants born to...
Recent studies examine metformin for long COVID prevention, resistance exercise for post-COVID recovery, mRNA vaccines in cancer care, and vascular risks in children.
